Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Osteoprotegerin is associated with markers of atherosclerosis and body fat mass in type 2 diabetes patients.

Osteoprotegerin is associated with markers of atherosclerosis and body fat mass in type 2 diabetes patients. Int J Cardiol. 2011 Mar 03; 147(2):335-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.